跳至主要内容
临床试验/NCT06729086
NCT06729086尚未招募不适用

Propofol vs Sevoflurane in Cardiac Surgery: a Randomized Clinical Trial During the Peroperative and Postoperative Phase

Saint-Joseph University0 个研究点目标入组 100 人开始时间: 2025年1月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
主要终点
determine the relationship between myocardial protection and type of anesthesia

研究概览

简要总结

The hypothesis of our study: presence of a relationship between the type of anesthesia and complications after cardiac surgery. The aim is to assess the benefit of using intravenous or inhaled anesthesia on the patients' stay and its complications.

详细描述

Cardiac surgery presents unique challenges for anesthesiologists as they are responsible for amnesia, analgesia, muscle relaxation, and maintenance of organ functions in the context of CPB-induced pathophysiological changes. Postoperative complications are vast and varied, leading to a prolonged stay in cardiac intensive care. However, the question of the superiority of one anesthesia protocol over another in cardiac surgery is debated.

The AHA (American Heart Association) recommended the use of inhalation anesthesia to reduce the risk of perioperative myocardial ischemia and infarction in 2011. However, in 2019, this recommendation lost a step in its level of proof and therefore the debate is still open.

Indeed, a "MYRIAD" study carried out on five continents determined that the administration of a halogenated volatile agent provided clinical benefit to patients undergoing coronary revascularization surgery. The study was randomized, single-blind, multicenter, carried out on patients scheduled for coronary bypass surgery with or without extracorporeal circulation (ECB).

Volatile halogenated agents (AVH) have cardioprotective properties via a pre- and post-conditioning phenomenon. Several meta-analyses have shown a benefit from the use of AVH during coronary surgery and in particular a reduction in mortality.

Note that the choice of type of anesthesia is made according to the habits of the department and the anesthetist and is in no way linked to the patient's condition or the intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all patients above 18 yeras old that will undergo a cardiac surgery

排除标准

  • below 18 yeras old

研究组 & 干预措施

sedation using propofol

Placebo Comparator

this group will include all patients who will receive propofol during the cardiac surgery and afterwards in the intensive care unit during the post operative phase

干预措施: sedation using propofol (Drug)

sedation using sevoflurane

Active Comparator

this group will include all patients who will receive sevoflurance druing the cardiac surgery and afterwards in the intensive care unit during the postoperative phase

干预措施: sedation using sevoflurane (Drug)

结局指标

主要结局

determine the relationship between myocardial protection and type of anesthesia

时间窗: 48 hours after the surgery

troponin T dosage

次要结局

  • Association between the type of anesthesia and the speed of awakening(48 hours after the surgery)
  • Association between the length of stay in intensive care and the type of anesthesia(72 hours after the surgery)
  • Determine a relationship between the type of anesthesia and the hemodynamic profile(48 hours after the surgery)
  • Association between the type of anesthesia and pulmonary complications(72 hours after the surgery)
  • Association between the type of anesthesia and neurological complications(72 hours after the surgery)

研究者

发起方
Saint-Joseph University
申办方类型
Other
责任方
Sponsor

相似试验

Propofol vs Sevoflurane in Cardiac Surgery | 临床试验